RARE DISEASE
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Longitudinal Registry Including Patients Treated With Heavy Particles (NCT05203250) | CNAO National Center of Oncological Hadrontherapy | 2021-06-04 |
| Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors (NCT02938793) | Prisma Health-Upstate | 2016-12-01 |
| Idiopathic Diseases of Man (NCT01440218) | Scripps Translational Science Institute | 2011-09-01 |
Track RARE DISEASE automatically
Every clearance here is in the API, with alerts when new ones post.